Kinfe G. Bishu
Medical University of South Carolina
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kinfe G. Bishu.
Diabetes Care | 2015
Mukoso N. Ozieh; Kinfe G. Bishu; Clara E. Dismuke; Leonard E. Egede
OBJECTIVE Direct medical cost of diabetes in the U.S. has been estimated to be 2.3 times higher relative to individuals without diabetes. This study examines trends in health care expenditures by expenditure category in U.S. adults with diabetes between 2002 and 2011. RESEARCH DESIGN AND METHODS We analyzed 10 years of data representing a weighted population of 189,013,514 U.S. adults aged ≥18 years from the Medical Expenditure Panel Survey. We used a novel two-part model to estimate adjusted mean and incremental medical expenditures by diabetes status, while adjusting for demographics, comorbidities, and time. RESULTS Relative to individuals without diabetes (
Journal of General Internal Medicine | 2016
Leonard E. Egede; Rebekah J. Walker; Kinfe G. Bishu; Clara E. Dismuke
5,058 [95% CI 4,949–5,166]), individuals with diabetes (
Journal of Affective Disorders | 2016
Leonard E. Egede; Kinfe G. Bishu; Rebekah J. Walker; Clara E. Dismuke
12,180 [11,775–12,586]) had more than double the unadjusted mean direct expenditures over the 10-year period. After adjustment for confounders, individuals with diabetes had
Journal of Risk Research | 2018
Kinfe G. Bishu; Seamus O’Reilly; Edward Lahiff; Bodo Steiner
2,558 (2,266–2,849) significantly higher direct incremental expenditures compared with those without diabetes. For individuals with diabetes, inpatient expenditures rose initially from
Health and Quality of Life Outcomes | 2017
Jennifer A. Campbell; Kinfe G. Bishu; Rebekah J. Walker; Leonard E. Egede
4,014 in 2002/2003 to
International Journal for Equity in Health | 2017
Tiarney D. Ritchwood; Kinfe G. Bishu; Leonard E. Egede
4,183 in 2004/2005 and then decreased continuously to
Journal of the Neurological Sciences | 2018
Alain Lekoubou; Kinfe G. Bishu; Bruce Ovbiagele
3,443 in 2010/2011, while rising steadily for individuals without diabetes. The estimated unadjusted total direct expenditures for individuals with diabetes were
Journal of the American Heart Association | 2018
Elizabeth B. Kirkland; Marc Heincelman; Kinfe G. Bishu; Samuel O. Schumann; Andrew D. Schreiner; R. Neal Axon; Patrick D. Mauldin; William P. Moran
218.6 billion/year and adjusted total incremental expenditures were approximately
Journal of Stroke & Cerebrovascular Diseases | 2018
Alain Lekoubou; Kinfe G. Bishu; Bruce Ovbiagele
46 billion/year. CONCLUSIONS Our findings show that compared with individuals without diabetes, individuals with diabetes had significantly higher health expenditures from 2002 to 2011 and the bulk of the expenditures came from hospital inpatient and prescription expenditures.
Epilepsy Research | 2018
Alain Lekoubou; Kinfe G. Bishu; Bruce Ovbiagele
ObjectiveTo investigate differences in healthcare cost trends over 8 years in adults with diabetes and one of four categories of comorbid depression: no depression, unrecognized depression, asymptomatic depression, or symptomatic depression.Research Design and MethodsData from the 2004–2011 Medical Expenditure Panel Survey (MEPS) was used to create nationally representative estimates. The dependent variable was total healthcare expenditures for the calendar year, including office-based, hospital outpatient, emergency room, inpatient hospital, prescription, dental, and home health care expenditures. The 2004–2011 direct medical costs were adjusted to a common 2014 dollar value. The primary independent variable was four mutually exclusive depression categories created from ICD-9-CM codes and the PHQ-2 depression screening tool. Healthcare expenditures were estimated using a two-part model and were adjusted for age, sex, race, marital status, education, health insurance, metropolitan statistical area status, region, income level, and comorbidities.ResultsBased on a national sample of adults with diabetes (unweighted sample of 15,548, weighted sample of 17,465,579), 10.2 % had unrecognized depression, 13.6 % had asymptomatic depression, and 8.9 % had symptomatic depression. In the pooled sample, after adjusting for covariates, the incremental cost of unrecognized depression was